AGFB Stock Overview
Develops, produces, and distributes various analog and digital imaging systems worldwide. More details
Snowflake Score | |
---|---|
Valuation | 4/6 |
Future Growth | 3/6 |
Past Performance | 0/6 |
Financial Health | 6/6 |
Dividends | 0/6 |
Agfa-Gevaert NV Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | €0.63 |
52 Week High | €1.59 |
52 Week Low | €0.68 |
Beta | 0.69 |
11 Month Change | -38.90% |
3 Month Change | -42.35% |
1 Year Change | -59.48% |
33 Year Change | -82.32% |
5 Year Change | -86.01% |
Change since IPO | -97.05% |
Recent News & Updates
Recent updates
It Looks Like Agfa-Gevaert NV's (EBR:AGFB) CEO May Expect Their Salary To Be Put Under The Microscope
May 08Agfa-Gevaert NV (EBR:AGFB) Held Back By Insufficient Growth Even After Shares Climb 27%
Mar 30Does Agfa-Gevaert (EBR:AGFB) Have A Healthy Balance Sheet?
Apr 28A Look At The Intrinsic Value Of Agfa-Gevaert NV (EBR:AGFB)
Apr 19Agfa-Gevaert NV's (EBR:AGFB) About To Shift From Loss To Profit
Mar 13Here's What Agfa-Gevaert NV's (EBR:AGFB) Shareholder Ownership Structure Looks Like
Feb 04A Look At Agfa-Gevaert's (EBR:AGFB) Share Price Returns
Dec 31Agfa-Gevaert (EBR:AGFB) Has A Somewhat Strained Balance Sheet
Nov 27Shareholder Returns
AGFB | BE Healthcare Services | BE Market | |
---|---|---|---|
7D | -32.4% | -2.8% | -1.8% |
1Y | -59.5% | -11.6% | 3.7% |
Return vs Industry: AGFB underperformed the Belgian Healthcare Services industry which returned -11.6% over the past year.
Return vs Market: AGFB underperformed the Belgian Market which returned 3.7% over the past year.
Price Volatility
AGFB volatility | |
---|---|
AGFB Average Weekly Movement | 7.0% |
Healthcare Services Industry Average Movement | 5.9% |
Market Average Movement | 3.3% |
10% most volatile stocks in BE Market | 6.4% |
10% least volatile stocks in BE Market | 2.1% |
Stable Share Price: AGFB's share price has been volatile over the past 3 months compared to the Belgian market.
Volatility Over Time: AGFB's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of Belgian stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1867 | 4,819 | Pascal Juery | www.agfa.com |
Agfa-Gevaert NV develops, produces, and distributes various analog and digital imaging systems worldwide. It operates through four segments: HealthCare IT, Digital Print & Chemicals, Radiology Solutions, and CONOPS. The company’s CONOPS segment engages in supply of film and chemicals, as well support services.
Agfa-Gevaert NV Fundamentals Summary
AGFB fundamental statistics | |
---|---|
Market cap | €105.90m |
Earnings (TTM) | -€32.00m |
Revenue (TTM) | €1.13b |
0.1x
P/S Ratio-3.1x
P/E RatioIs AGFB overvalued?
See Fair Value and valuation analysisEarnings & Revenue
AGFB income statement (TTM) | |
---|---|
Revenue | €1.13b |
Cost of Revenue | €774.00m |
Gross Profit | €352.00m |
Other Expenses | €384.00m |
Earnings | -€32.00m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -0.21 |
Gross Margin | 31.26% |
Net Profit Margin | -2.84% |
Debt/Equity Ratio | 48.6% |
How did AGFB perform over the long term?
See historical performance and comparison